BiotechTube
Home/Adaptin Bio/Michael J. Roberts, Ph.D.
MJ

Michael J. Roberts, Ph.D.

Co-Founder and CEO

Adaptin Bio

Therapeutic Areas

OncologyCentral Nervous System (CNS)

Adaptin Bio Pipeline

DrugIndicationPhase
APTN-101EGFRvIII-positive malignant gliomas / brain tumorsPre-clinical